(Q70131429)
Statements
A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis (English)
M B Bornstein
A Miller
S Slagle
M Weitzman
E Drexler
M Keilson
V Spada
W Weiss
S Appel